Neuromuscular Fellowship Funding Competition Recipients
The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are excited to announce the recipients of a funding competition, which awarded national post-doctoral fellowships in neuromuscular research and clinical fellowships in neuromuscular medicine and electromyography.
This competition saw many incredible applicants and involved a thorough and extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the most promising and top-ranked researchers, and leaders in neuromuscular care, received funding.
Post-doctoral fellowship recipients:
Dr. Yuguo Liu
Université de Sherbrooke
Post-doctoral Supervisor: Dr. Florian Bentzinger
Title of Research: Targeting the Perivascular MuSC Niche for the Treatment of Muscular Dystrophy
Sean Ng, Ph.C.
McMaster University
Post-doctoral Supervisors: Dr. Mark Tarnopolsky and Dr. Joshua Nederveen
Title of Research: Determining the Therapeutic Potential of AMP-activated Protein Kinase in Myotonic Dystrophy Type 2
Dr. Matthew Triolo
University of Ottawa
Post-doctoral Supervisor: Dr. Mireille Khacho
Title of Research: Targeting mitochondrial dynamics and metabolites to restore muscle stem cell function in Duchenne Muscular Dystrophy
Clinical fellowship recipients:
Dr. Gloria Mak
Training institution: University of Alberta
Dr. Béatrice Soucy
Training institution: University of Calgary
Dr. Neha Patel
Training institution: Sunnybrook Health Sciences Centre, University of Toronto
NMD4C and MDC extend special thanks to the Canadian Society of Clinical Neurophysiologists (CSCN) for jointly funding a clinical fellow this year.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.